Pioneering Research in the 21st Century: The First Joint Symposium for Scientists and Consumers
On June 26 and 27, 2002, the National Stuttering Association (NSA) gathered speech researchers, speech-language pathologists, and people who stutter for a “joint symposium” on stuttering research. The meeting, entitled Pioneering Stuttering Research in the 21st Century, was designed to encourage a dialogue between scientists and people who stutter regarding issues of importance in the study of fluency disorders. Participants worked in small groups to discuss a variety of topics reflecting current research priorities from across the field. Discussion topics included early intervention and identification of risk factors for developing stuttering, treatment outcomes, research, relationships between brain functioning and speech behavior, attitudes toward people who stutter, and interactions between linguistic and motor factors in the development of stuttering. Each working group evaluated a series of questions about goals for future research and discussed roadblocks to achieving those goals. Through their discussions, participants identified several key areas where further research is needed and brainstormed about novel approaches for meeting those research needs. Among the many outcomes of the meeting was the initiation of several collaborations among research scientists, as well as new partnerships between scientists and consumers. These collaborations hold significant promise for improving the understanding of the stuttering disorder and the treatment of people who stutter. Less tangible outcomes include a greater sense of understanding of the disorder for people who stutter, clinicians, and researchers and an increased sense of partnership among these groups as they continue to work toward addressing research needs in the future.
To receive the full summary and proceedings, follow the link below.
Pioneering Research in the 21st Century was made possible through support from the American-Speech-Language-Hearing Association, as well as an educational grant from Eli Lilly and Company.
|
 |
|
